Clinic significance of microRNA-99a expression in human lung adenocarcinoma

Journal of Surgical Oncology

Volumn 108, Issue 4, 2013, Pages 248-255

  Gu, Wei ^a   Fang, Surong ^a   Gao, Lihua ^a   Tan, Yan ^a   Yang, Zhenhua ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

lung adenocarcinoma; microRNA 99a; mTOR; prognosis; qRT PCR

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; MICRORNA; MICRORNA 99A; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ADULT; APOPTOSIS; ARTICLE; BRONCHUS MUCOSA; CANCER CELL; CANCER CELL CULTURE; CANCER PROGNOSIS; CANCER SURVIVAL; FEMALE; GENE EXPRESSION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LUNG ADENOCARCINOMA; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

LUNG ADENOCARCINOMA; MICRORNA-99A; MTOR; PROGNOSIS; QRT-PCR;

ADENOCARCINOMA; ADULT; AGED; APOPTOSIS; CELL LINE, TUMOR; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REAL-TIME POLYMERASE CHAIN REACTION; TOR SERINE-THREONINE KINASES;

EID: 84882456534     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23381     Document Type: Article

References (28)

1. Siegel R, Naishadham D, Jemal A:, Cancer statistics, 2012. CA Cancer J Clin 2012; 62: 10-29.
2. Houwen L:, State of the art: Lung cancer in China. Ann Thorac Cardiovasc Surg 2003; 9: 147-148.
3. Ke XS, Liu CM, Liu DP, et al.: MicroRNAs: Key participants in gene regulatory networks. Curr Opin Chem Biol 2003; 7: 516-523.
4. Jansson MD, Lund AH:, MicroRNA and cancer. Mol Oncol 2012; 6: 590-610.
5. Chen PS, Su JL, Hung MC:, Dysregulation of microRNAs in cancer. J Biomed Sci 2012; 19: 90.
6. Li C, Hashimi SM, Good DA, et al.: Apoptosis and microRNA aberrations in cancer. Clin Exp Pharmacol Physiol 2012; 39: 739-746.
7. Bueno MJ, Malumbres M:, MicroRNAs and the cell cycle. Biochim Biophys Acta 2011; 1812: 592-601.
8. Zhang J:, Ma L: MicroRNA control of epithelial-mesenchymal transition and metastasis. Cancer Metastasis Rev 2012; 31: 653-662.
9. Chistiakov DA, Chekhonin VP:, Contribution of microRNAs to radio- and chemoresistance of brain tumors and their therapeutic potential. Eur J Pharmacol 2012; 684: 8-18.
10. Qi J, Mu D:, MicroRNAs and lung cancers: From pathogenesis to clinical implications. Front Med 2012; 6: 134-155.
11. Roybal JD, Zang Y, Ahn YH, et al.: MiR-200 Inhibits lung adenocarcinoma cell invasion and metastasis by targeting Flt1/VEGFR1. Mol Cancer Res 2011; 9: 25-35.
12. Cai J, Wu J, Zhang H, et al.: miR-186 downregulation correlates with poor survival in lung adenocarcinoma, where it interferes with cell-cycle regulation. Cancer Res 2013; 73: 756-766.
13. Feng B, Wang R, Song HZ, et al.: MicroRNA-200b reverses chemoresistance of docetaxel-resistant human lung adenocarcinoma cells by targeting E2F3. Cancer 2012; 118: 3365-3376.
14. Kaduthanam S, Gade S, Meister M, et al.: Serum miR-142-3p is associated with early relapse in operable lung adenocarcinoma patients. Lung Cancer 2013; 80: 223-227.
15. Cui L, Zhou H, Zhao H, et al.: MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinoma. BMC Cancer 2012; 12: 546.
16. Yan B, Fu Q, Lai L, et al.: Downregulation of microRNA 99a in oral squamous cell carcinomas contributes to the growth and survival of oral cancer cells. Mol Med Rep 2012; 6: 675-681.
17. Li D, Liu X, Lin L, et al.: MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma. J Biol Chem 2011; 286: 36677-36685.
18. Du L, Pertsemlidis A:, microRNAs and lung cancer: Tumors and 22-mers. Cancer Metastasis Rev 2010; 29: 109-122.
19. Wu X, Piper-Hunter MG, Crawford M, et al.: MicroRNAs in the pathogenesis of lung cancer. J Thorac Oncol 2009; 4: 1028-1034.
20. Torres A, Torres K, Pesci A, et al.: Deregulation of miR-100, miR-99a and miR-199b in tissues and plasma coexists with increased expression of mTOR kinase in endometrioid endometrial carcinoma. BMC Cancer 2012; 12: 369.
21. Chen Z, Jin Y, Yu D, et al.: Down-regulation of the microRNA-99 family members in head and neck squamous cell carcinoma. Oral Oncol 2012; 48: 686-691.
22. Sun J, Chen Z, Tan X, et al.: MicroRNA-99a/100 promotes apoptosis by targeting mTOR in human esophageal squamous cell carcinoma. Med Oncol 2013; 30: 411.
23. Clancy JL, Nousch M, Humphreys DT, et al.: Methods to analyze microRNA-mediated control of mRNA translation. Methods Enzymol 2007; 431: 83-111.
24. Behm-Ansmant I, Rehwinkel J, Izaurralde E:, MicroRNAs silence gene expression by repressing protein expression and/or by promoting mRNA decay. Cold Spring Harb Symp Quant Biol 2006; 71: 523-530.
25. Rajewsky N:, microRNA target predictions in animals. Nat Genet 2006; 38: S8-S13.
26. Hay N, Sonenberg N:, Upstream and downstream of mTOR. Genes Dev 2004; 18: 1926-1945.
27. Weber JD, Gutmann DH:, Deconvoluting mTOR biology. Cell Cycle 2012; 11: 236-248.
28. Ekman S, Wynes MW, Hirsch FR:, The mTOR pathway in lung cancer and implications for therapy and biomarker analysis. J Thorac Oncol 2012; 7: 947-953.